InMed featured in this article about the different cannabinoid manufacturing technologies that are shaping the industry. The article by Edison also talks about the cannabinoid market and recent partnerships.
Excerpt:
The cannabis market is growing fast. According to BDSA, cannabis sales grew by 50% and 41% in 2020 and 2021 respectively, which brought 2021 sales to US$31bn. The demand for isolated cannabinoids is also growing, with Grand View Research estimating the cannabinoid market was worth US$4.5bn in 2020 and forecasting a CAGR of 20.4% until 2027, which would take the market size to US$16.4bn. The demand is driven by the wellness and pharmaceutical industries. A variety of manufacturing methods are being developed that have the potential to produce industrial-scale, low-cost, high-quality cannabinoids. Manufacturing innovations in extraction, chemical synthesis, biosynthesis and biotransformation are all attracting significant investment.
